Life Sciences

The capital of Minas Gerais
has the largest number
of health facilities per citizen

In demographic terms, there are two main characteristics of Brazilian population that drive this segment and may keep on influencing it along the next years.

Firstly, the Brazilian population is growing older. As the population lives longer, it is observed a higher incidence of age related diseases which demand specific diagnostics and treatments. The second is due to the fact that, in one decade, the largest part of the population will be aged between 20 and 49, i.e., in a productive age. As people enter the job market, the potential for consumption reaches higher levels due to a higher income available for health related expenses.

Health facilities in Belo Horizonte, the capital of Minas Gerais:

Federal: 4
State: 17
City: 207
Private: 854

Investment opportunities: Bovine genetics; R&D Centers; Pharmaceuticals; Medical equipment.


Workforce costs lower than national average.

The workforce costs of this segment in Minas Gerais are 29,4% lower than average in the states of São Paulo and Rio de Janeiro.

Comparative Advantages

2nd state in Brazil regarding the number of companies operating in the biotechnology segment

The number of companies of this segment in Minas Gerais corresponds to 30% of total companies in Brazil. The state has three distinct hubs covering human, plant and animal biotechnology.
Currently, there are 22 STIs (Science and Technology Institutions) in Minas Gerais; 19 TIHs (Technology Innovation Centers); 11 Innovation Networks; 3 Hubs; 3 Technological Parks; 5 LPAs (Local Productive Arrangements); 6 Incubators; 5 Finance Fostering Institutions; 11 Supporting Institutions for this Segment.


One of the main biotechnology Centers of South America is located in Minas Gerais

The Life Science hubs in the state are located in TriânguloMineiro (the Triangle of Minas), Zona da Mata (a Forest Zone) and Belo Horizonte Metropolitan Region, RMBH.

One of the main biotechnology centers of South America, focused on Human and Animal Health, is located in the RMBH. The center is expected to directly and indirectly employ 5000 people.

The segment is comprised by: Embrapa, Fiocruz, Hemominas, Funed, Biominas, Novo Nordisk, GE Healthcare, Biomm Technology.

The Universities in Minas Gerais offer highly qualified workforce education. Universidade Federal de Minas Gerais (UFMG), FundaçãoHemominas (Hemominas Foundation) and Fundação Oswaldo Cruz René Rachou Institute are among the main educational institutions for the segment.

UFMG has over 161 researchers who hold Biological Science Doctor Degrees and is the major Brazilian University regarding patents, including international ones. Over 60% of its patents are related to Biotechnology. Universidade Federal de Uberlândia (UFU) Biomedicine degree is the 5th best in Brazil and the 3rd best evaluated in the market. Both UFMG and UFU are within the Top 10 regarding Master and Doctor degrees.
Source: Ranking UniversitárioFolha 2014

Chemical Engineering Degree - UFMG- 3rd best in Brazil, 1st in market evaluation.
UFU is amongst the 10th best in Brazil, 4th best regarding Doctor and Master degrees.
Source: Ranking UniversitárioFolha 2014 (Ranking of Universities, published by the newspaper Folha de São Paulo, in 2014).

Pharmacy Degree - UFMG- 2nd best in Brazil, 1st in market evaluation.
Source: Ranking UniversitárioFolha 2014

Medicine Degree - UFMG- 5th best in Brazil, 1st in market evaluation.
UFTM- Top 10 in education quality
Source: Ranking UniversitárioFolha 2014

Biology Degree-UFMG - The best in Brazil.
Chemistry Degree - UFMG- 3rd best in Brazil, 1st in education quality.

    UFMG- Post-Graduation in Biochemistry and Immunology;
  • Genetics
  • Microbiology
  • Parasitology
  • Bio-Informatics
  • Cellular
  • Biology

How to Start a business in Brazil?